. Earth Science News .
EPIDEMICS
Hard-hit Czech Republic turns to Russian jabs after EU delays
by AFP Staff Writers
Prague (AFP) Feb 28, 2021

The hard-hit Czech Republic has requested a delivery of Russia's Sputnik V vaccine in response to the delayed arrival of EU-procured jabs and will also consider Chinese inoculations, the president said Sunday.

The EU member tops the world in new infections per 100,000 people over the last 14 days and is second only to neighbouring Slovakia in deaths, according to an AFP tally.

The vaccination rollout is slower than expected with only 650,000 jabs administered since December in the country of 10.7 million people, which Czech politicians blame on slow procurement by the EU.

"After consulting the prime minister, I have sent a letter to (Russian President) Vladimir Putin, asking him for a supply of the Sputnik vaccine," President Milos Zeman said on TV Prima.

"Information from the Russian embassy suggests it could arrive in the next few days," said the pro-Russian, pro-Chinese leader.

He said he would not mind if the country used the Chinese Sinopharm vaccine either as "vaccines have no ideology".

Neither Sputnik V nor Sinopharm have been approved by the European Union regulator EMA, unlike the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford vaccines currently used in the Czech Republic.

But Zeman and Czech Prime Minister Andrej Babis said they would not wait for the EMA to give the green light.

"All we need is a stamp from the (Czech) State Office for Drug Control," said Babis, who visited Hungary and Serbia earlier this month to learn about the two vaccines.

"Sixty-five countries in the world want the Russian vaccine, including six EU countries, so why say, 'Jesus, it's terrible'?" said Babis.

"Believe me when I say that EU member states will also be asking for Sputnik in a few months," added the billionaire populist, who -- like Zeman -- has already received both jabs of the Pfizer/BioNTech vaccine.

Hungary PM Orban receives Chinese virus jab
Budapest (AFP) Feb 28, 2021 - Hungarian Prime Minister Viktor Orban was vaccinated with a Chinese-made jab days after Hungary became the first EU member to use the vaccine, which has not been approved by EU regulators.

"I am vaccinated," said a post on Orban's official Facebook page alongside photographs and a video showing him receiving a jab from a medical assistant holding a Sinopharm box.

Neither Sinopharm nor Russia's Sputnik V jab, which Budapest also started rolling out this month in another EU first, are approved by the bloc's European Medicines Agency (EMA).

But Orban, who has blamed the EU for failing to deliver vaccines fast enough, has urged citizens to put aside concerns about the Chinese vaccine while pro-government media have also promoted its benefits.

President Janos Ader also received a Sinopharm shot Friday a day after the country's chief surgeon announced the start of mass inoculations with the vaccine.

The first batch of 550,000 Sinopharm jabs from China arrived in Hungary earlier this month accompanied by fanfare in public media.

Budapest expects to get a further one million doses in March and April in total, with 3.5 million more doses arriving in May.

So far, almost half a million Hungarians have received at least one vaccine dose, mostly Pfizer shots, but officials say that the pace of inoculations will double with the newly procured Chinese jabs.

In surveys of preferences among the five vaccines now used in Hungary, Sinopharm ranks last behind three western-developed vaccines -- Pfizer-BioNTech, Moderna and AstraZeneca -- as well as Sputnik V.

The inoculation drive comes as an extension of a partial lockdown in place from November until March 15 was announced Thursday following a steep rise in new infection cases.

"Without the Chinese and Russian vaccines we would be in big trouble," Orban said Friday.

Orban's critics have accused the 57-year-old premier of pressuring health authorities to approve non-EU vaccines to win favour from China and Russia.

A government decree last month drastically loosened approval criteria of vaccines worldwide.

A leading doctors association said it could not recommend the Chinese or Russian drugs to colleagues "in good conscience" due to inadequate documentation.

Philippines receives first Covid-19 vaccines from China
Manila (AFP) Feb 28, 2021 - The Philippines received 600,000 vaccine doses from China Sunday, kickstarting the country's inoculation drive despite concerns over the Sinovac jab's effectiveness.

Top government officials and health workers will be the first on Monday to receive the Chinese-made vaccine -- called CoronaVac -- just days after the drug regulator approved it for emergency use.

President Rodrigo Duterte, whose government has been under fire over delays in procuring vaccines, oversaw the delivery of the doses at a military air base.

Around 525,000 doses of AstraZeneca jab, distributed as part of the global Covax global inoculation programme, were also supposed to arrive on Monday, but Health Secretary Francisco Duque later said the shipment will be delayed for a week due to global supply problems.

The regulator did not recommend CoronaVac for healthcare workers due to its comparatively low efficacy.

An advisory group to the Philippine government allowed it to be offered to those willing to take it, but many nurses and doctors are reluctant and have opted to wait for other vaccines.

In the Philippine General Hospital, one of the country's main facilities treating Covid-19 patients, only 10 percent of staff were willing to be inoculated with the Chinese-made vaccine, spokesman Jonas Del Rosario told AFP.

It was far from the 94 percent who registered to take the Pfizer-BioNTech jab, said Del Rosario, who himself opted not to take the CoronaVac shot.

The hesitancy is not new in the Southeast Asian nation, which has struggled with vaccine programmes in recent years.

The Philippines was the first country in 2016 to deploy the dengue vaccine Dengvaxia, but a botched rollout led to unfounded claims that several dozen children had died from the jab.

Recent surveys have shown vaccine confidence remains low, with almost half of the population reportedly unwilling to be inoculated against the coronavirus.

To boost trust, several top officials -- including the health minister -- are expected to receive the CoronaVac jab.

President Duterte, who has defended Chinese-made vaccines, suggested he will be inoculated in public, having previously said he would receive it in private.

But the 75-year-old leader's doctors are still deciding which vaccine to use for him.

The rollout came as the number of daily new infections in the Philippines hit a four-month high. More than 570,000 cases have been confirmed, including over 12,000 deaths.

Aside from hospital workers, the military is set to receive 100,000 Sinovac doses.

Members of the Philippines armed forces are required to get vaccinated and those who refuse could be disciplined.

The government is in talks with seven vaccine makers, including Sinovac, in the hope of securing enough doses to inoculate 70 million people -- about 60 percent of the population -- this year.

But the bulk of the supply is not expected to start arriving until the summer.


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Privacy faces risks in tech-infused post-Covid workplace
Washington (AFP) Feb 21, 2021
People returning to work following the long pandemic will find an array of tech-infused gadgetry to improve workplace safety but which could pose risks for long-term personal and medical privacy. Temperature checks, distance monitors, digital "passports," wellness surveys and robotic cleaning and disinfection systems are being deployed in many workplaces seeking to reopen. Tech giants and startups are offering solutions which include computer vision detection of vital signs to wearables which ca ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
DHS expects troops to assist with border enforcement for 3 to 5 more years

UN rights chief hails US shift from Trump migration policies

Biden tours Texas storm relief efforts

In gritty Paris suburb, virus sparks 'social tsunami'

EPIDEMICS
Polymer film protects from electromagnetic radiation, signal interference

Researchers grow artificial hairs with clever physics trick

Brand new findings on fire safety in space

China's appetite for copper provides Chile with opportunity

EPIDEMICS
Tool that more efficiently analyzes ocean color data will become part of NASA program

Flood-prone Miami to spend billions tackling sea level rise

Study: Gulf Stream System is the weakest it's been in 1,000 years

Texans queue for water as US counts cost of deadly winter storm

EPIDEMICS
Giant iceberg breaks off near UK Antarctic base

Effects of past ice ages more widespread than previously thought

Ancient relic points to a turning point in Earth's history 42,000 years ago

India's glacier disaster highlights Himalayan dangers

EPIDEMICS
Beyond Meat signs long-term agreements with McDonald's, KFC parent

Colombia's apiarists say avocado buzz is killing bees

Three technologies poised to change food and the planet

Measuring carbon nanotubes taken up by plants

EPIDEMICS
Quake rocks Reykjavik, raises Iceland's volcano activity

Severe floods kill five in Indonesia's capital

Indonesia volcano erupts, spews red-hot lava

Quake injures more than 30 in southwest Iran

EPIDEMICS
Widow of slain Italian ambassador says he was 'betrayed'

Burkina Faso military kills 11 'terrorists'

Tanzanian bow-and-arrow hunters offer insight on evolution of technology

U.S. Navy ship visits Sudan in show of partnership

EPIDEMICS
Outsider threats inspire bonding, cooperation among chimpanzees

Study: Social media users behave a lot like animals searching for food

For more equitable cities, researchers say to keep social networks intact

CT scans of Egyptian mummy suggest 'brave' pharaoh was executed









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.